Literature DB >> 29653785

Icatibant for the treatment of orolingual angioedema following the administration of tissue plasminogen activator.

Emily Brown1, Christina Campana2, Jacob Zimmerman1, Steven Brooks3.   

Abstract

Entities:  

Keywords:  Airway management; Angioedema; Icatibant; Stroke; Tissue plasminogen activator

Mesh：

Substances：

Year:  2018        PMID： 29653785     DOI： 10.1016/j.ajem.2018.03.018

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  3 in total

1.  Incidence of orolingual angioedema after intravenous thrombolysis for stroke.

Authors:  Bruno Censori; T Partziguian; V Bonito; M Sgarzi; R Riva; D Alimonti; E Agazzi; M Vedovello; B Frigeni; E Venturelli; S La Gioia; V Barcella; L Daleffe; L Longhi; F Ferri; R Cosentini; M R Rottoli
Journal:  Neurol Sci       Date:  2018-08-06       Impact factor: 3.307

2.  A mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogen.

Authors:  S Kent Dickeson; Sunil Kumar; Mao-Fu Sun; Bassem M Mohammed; Dennis R Phillips; James C Whisstock; Adam J Quek; Edward P Feener; Ruby H P Law; David Gailani
Journal:  Blood       Date:  2022-05-05       Impact factor: 25.476

3.  A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy.

Authors:  Mohamed Shirazy; Anis Chaari; Karim Hakim; Kamel Bousselmi; Vipin Kauts
Journal:  Drug Saf Case Rep       Date:  2019-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.